Method for determining the content of characteristic components of Radix Bupleuri and its preparations by liquid chromatography-mass spectrometry

Through the use of high-resolution mass spectrometry technology for liquid-related combinations, the content of 13 kinds of Bupleurum saponins in Chaihu medicinal materials, decoctions and their extracts was simultaneously measured within 20 minutes, solving the problem that is difficult to determine simultaneously in the prior art and improving the The accuracy and scientific nature of quality control.

CN113030340BActive Publication Date: 2024-11-26BEIJING INST OF DRUG INSPECTION (BEIJING VACCINE INSPECTION CENT)
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202110387399.3
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2021-04-09
Publication Date
2024-11-26
Estimated Expiration
2041-04-09

AI Technical Summary

Technical Problem

The existing methods are difficult to simultaneously determine the content of 13 characteristic saponins of Bupleurum medicinal materials, decoctions and their extracts, especially lacking effective monitoring methods in quality control.

Method used

The high-resolution mass spectrometry technology for liquid-associated phase is adopted, and the high-resolution mass spectrometry of ultra-high performance liquid chromatography tandem electrostatic field orbital traps is combined with gradient elution and gradient mass spectrometry conditions to achieve simultaneous determination and quantification of Bupleurum saponins.

Benefits of technology

The content of 13 kinds of Chaihu saponins can be measured and quantified simultaneously within 20 minutes, which improves the scientificity and accuracy of Chaihu preparation quality control and is suitable for the quality monitoring of Chaihu medicinal materials, decoctions and their extracts.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN113030340B_ABST
    Figure CN113030340B_ABST
Patent Text Reader

Abstract

The present invention relates to a method for determining the content of characteristic components of Bupleurum and its preparations by liquid chromatography-mass spectrometry, and specifically to a method for determining the content of saikosaponin in Bupleurum medicinal material slices, Bupleurum extracts such as water extracts thereof or Bupleurum preparations, wherein the method uses liquid chromatography-mass spectrometry to simultaneously determine the saikosaponin in the Bupleurum preparations and calculate the content thereof. The Bupleurum preparations are selected from Bupleurum granules, Bupleurum capsules, Bupleurum tablets, Bupleurum oral liquid, and Bupleurum soft capsules. The saikosaponin includes one or more combinations selected from the following 13 saponins: saikosaponin A, saikosaponin B1, saikosaponin B2, saikosaponin C, saikosaponin D, saikosaponin F, saikosaponin G, saikosaponin H, saikosaponin I, nipo saikosaponin K, saikosaponin S, prosapogenin D, and prosapogenin F. The method of the present invention can simultaneously determine 13 characteristic components of Bupleurum in a relatively short time and quantify them.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention belongs to the field of medical technology, and relates to a method for determining the quality of traditional Chinese medicine and its preparations, and specifically relates to a method for determining the content of characteristic components of bupleurum in bupleurum medicinal materials, decoction pieces and extracts thereof, such as water extracts thereof or bupleurum preparations, by using liquid phase coupling high-resolution mass spectrometry. The method of the present invention can simultaneously determine 13 characteristic components of bupleurum within 20 minutes and quantify them. Background Art

[0002] The Chinese Pharmacopoeia 2020 Edition Volume 1 contains the medicinal material Bupleurum radix, which is the dried root of Bupleurum chinense DC. or Bupleurum scorzonerifolium Willd. of the Apiaceae family. According to their different properties, they are commonly known as "Northern Bupleurum" and "Southern Bupleurum". They are dug in spring and autumn, the stems, leaves and mud are removed, and then dried.

[0003] Chaihuang preparations are made from two Chinese medicinal materials, Bupleurum and Scutellaria, and are commonly used in the form of granules, tablets, capsules, and soft capsules. They have the effect of clearing away heat and relieving symptoms, and are commonly used in clinical practice for wind-heat colds, with symptoms of fever, general discomfort, headache, dizziness, and sore throat. In addition, Chaihuang preparations also have the effect of clearing heat and reducing inflammation, and are commonly used in clinical practice for upper respiratory tract infections and colds and fevers.

[0004] The Chaihuang Tablets included in the 2020 edition of the Chinese Pharmacopoeia are made of 1000g of Bupleurum and 1000g of Scutellaria baicalensis after extraction and adding appropriate excipients per 1000 tablets. The Chaihuang Oral Liquid included in the 2020 edition of the Chinese Pharmacopoeia is made of 500g of Bupleurum and 500g of Scutellaria baicalensis after extraction and adding appropriate excipients per 1000ml. The Chaihuang Granules included in the National Drug Standard WS3-B-2009-95-2008 of the State Food and Drug Administration are made of 1250g of Bupleurum and 90g of Scutellaria baicalensis extract per 1000g and adding appropriate excipients. The Chaihuang Capsules included in the National Drug Standard YBZ02362006 of the State Food and Drug Administration are made of Bupleurum and Scutellaria baicalensis, and each capsule contains more than 45mg of baicalin. The quality of these preparations is controlled by the content of baicalin, and there is a lack of monitoring of the use of Bupleurum in the preparations.

[0005] The main components of Bupleurum are saikosaponins, which are composed of a series of characteristic saponins, such as Saikosaponin A, Saikosaponin B1, Saikosaponin B2, Saikosaponin C, Saikosaponin D, Saikosaponin F, Saikosaponin G, Saikosaponin H, Saikosaponin I, Nepasaikosaponin K, Saikosaponin S, Prosapogenin D, Prosapogenin F, etc. There are 13 kinds of these saponins, the chemical structures and physicochemical properties of which are similar, and there is no report on separating them simultaneously by conventional liquid chromatography with an ultraviolet detector.

[0006] Although there are literature reports on the simultaneous determination of a few saponins, there is no method for the simultaneous determination of 13 saikosaponins.

[0007] For example, Wen Shuang's literature (Wen Shuang, et al., Determination of saikosaponins a, b1, c, d and baicalin in Chaihuang granules by HPLC, Journal of Drug Analysis, Issue 01, 2017, pp. 148-152) records an HPLC method for determining the contents of saikosaponins a, b1, c, d and baicalin in Chaihuang granules. This method uses SB-C 18The chromatographic column (250mm×4.6mm, 5.0μm) was used, with acetonitrile (A)-0.01% phosphoric acid aqueous solution (B) as the mobile phase, gradient elution (0-30min, 30%A→60%A; 30-35min, 60%A), flow rate 1mL / min, detection wavelength 210nm. Results: The sample was ultrasonically extracted with 5% concentrated ammonia methanol solution for 30min, and the mass concentrations of saikosaponin a, b1, c, d and baicalin were in the range of 3.6-36.0, 6.0-60.0, 8.4-84.0, 9.2-92.0 and 10.0-100.0μg / mL, respectively (r≥0.999 2); The precision, stability and repeatability of the method were good, and the RSD was less than 2.0%; the average recoveries of saikosaponin a, b1, c, d and baicalin were 97.5%, 95.3%, 99.7%, 98.4% and 95.1%, and the RSD was less than 2.0%; the contents of saikosaponin a, b1, d and baicalin in the three batches of samples were 1.560-1.573, 7.501-7.587, 9.204-9.356 and 11.635-11.817 mg / g, respectively, and saikosaponin c was not detected. The authors of the literature believe that the method can be used for the determination of saikosaponin a, b1, c, d and baicalin in Chaihuang Granules after methodological verification, and can provide a scientific basis for the comprehensive quality control of Chaihuang Granules.

[0008] Yan Jie's literature (Yan Jie, et al., HPLC determination of saikosaponin a, c, d in the aboveground and underground parts of four kinds of Sichuan Bupleurum, Chinese Journal of Experimental Traditional Chinese Medicine, Issue 13, 2014, Pages 73-76) records the method for determining the content of saikosaponin a, c, d in different varieties and different medicinal parts of Sichuan Bupleurum. The method uses an Agilent TC-C18 chromatographic column (4.6mm×250mm, 5μm), a mobile phase of acetonitrile-water, gradient elution, a flow rate of 1mL / min, a detection wavelength of 210nm, and a column temperature of 30°C. As a result, saikosaponin a, c, and d showed a good linear relationship with the peak area in the range of 0.753-22.590, 0.461-13.830, and 0.726-21.780μg, respectively, and the average sample recovery rates were 100.83%, 99.96%, and 101.12%, respectively. The authors of the literature believe that the content of bupleurum saponin varies greatly in different varieties and different medicinal parts.

[0009] The inventors tried to use the above literature methods, but found that they could not simultaneously determine the above 13 saikosaponins. Therefore, those skilled in the art expect to have a new method to determine the content of saikosaponins in Bupleurum medicinal materials, decoction pieces and extracts thereof such as water extracts and Bupleurum preparations, especially to simultaneously determine the content of the above 13 saikosaponins. Summary of the invention

[0010] The object of the present invention is to provide a method for determining the content of saikosaponins in bupleurum medicinal materials, decoction pieces and extracts thereof such as water extracts and bupleurum preparations, and in particular to provide a method for simultaneously determining the content of 13 saikosaponins in bupleurum medicinal materials, decoction pieces and extracts thereof such as water extracts and bupleurum preparations. The present invention surprisingly found that the chromatography-mass spectrometry detection of 13 saponins can be completed within 20 minutes by the method of the present invention. The present invention is completed based on such a discovery.

[0011] To this end, the first aspect of the present invention provides a method for determining the content of saikosaponin in Bupleurum medicinal materials, decoction pieces and extracts thereof, such as water extracts or Bupleurum preparations. The method uses high performance liquid chromatography high resolution mass spectrometry to simultaneously determine the saikosaponin in the Bupleurum preparation and calculate its content.

[0012] According to the method of the first aspect of the present invention, the Chaihuang preparation is selected from Chaihuang granules, Chaihuang capsules, Chaihuang tablets, Chaihuang oral liquid, and Chaihuang soft capsules. Preferably, the Chaihuang preparation is selected from Chaihuang granules, Chaihuang capsules, and Chaihuang tablets.

[0013] According to the method of the first aspect of the present invention, the saikosaponin comprises one or more combinations selected from the following 13 saponins: Saikosaponin A, Saikosaponin B1, Saikosaponin B2, Saikosaponin C, Saikosaponin D, Saikosaponin F, Saikosaponin G, Saikosaponin H, Saikosaponin I, Nepasaikosaponin K, Saikosaponin S, Prosapogenin D, and Prosapogenin F.

[0014] The high-resolution mass spectrometer for liquid chromatography can be selected from: Waters QTof high-resolution mass spectrometer, Agilent iFunnel Q-TOF high-resolution mass spectrometer, Themo Fisher quadrupole-electrostatic field orbital trap high-resolution mass spectrometer (UPLC-Q Exactive-MS), Themo Fisher ion well-orbitrip high-resolution mass spectrometer, SCIEX QTOF high-resolution mass spectrometer, AB Qtof high-resolution time-of-flight mass spectrometer system, Shimadzu Q-Tof high-resolution mass spectrometer, etc.

[0015] According to the method of the first aspect of the present invention, the chromatographic conditions of the liquid phase high-resolution mass spectrometry (such as ultra-high performance liquid chromatography tandem electrostatic field orbital trap high-resolution mass spectrometry) are as follows: the chromatographic column is phenomenex C18 (2.1×150mm, 1.7μm), 0.1% formic acid solution is used as mobile phase A, methanol is used as mobile phase B, gradient elution is used, and the flow rate is 0.25mL / min. The elution gradient is as follows: 0-1min, 2% B; 1.0-2.5min, 2%-60% B; 2.5-6.5min, 60%-90% B; 6.5-7.5min, 90%-100% B; 7.5-9.5min, 100% B; 9.5-9.6min, 100%-2% B; 9.6-15.0min, 12% B. The column temperature is 25°C and the injection volume is 5μL.

[0016] According to the method of the first aspect of the present invention, the mass spectrometry conditions of the liquid phase high-resolution mass spectrometry (such as ultra-performance liquid chromatography tandem electrostatic field orbital trap high-resolution mass spectrometry) are as follows: mass spectrometry conditions: positive and negative ion online detection mode, ESI source, ion source temperature 300°C, capillary temperature 350°C; cone voltage 3.0 kV; sheath gas flow 50 psi; auxiliary gas flow 10 psi; S-Lens RF is 30%, scanning range m / z110-800; resolution 75000.

[0017] According to the method of the first aspect of the present invention, the quantitative molecular weights and chemical formulas of the 13 saponins determined by liquid chromatography-tandem electrostatic field orbital trap high-resolution mass spectrometry (such as ultra-performance liquid chromatography-tandem electrostatic field orbital trap high-resolution mass spectrometry) are as listed below.

[0018] According to the method of the first aspect of the present invention, the method for preparing the mixed reference solution for calculating the reference and the method for preparing the standard curve are as follows: accurately weigh appropriate amounts of each reference substance, and the weighed amounts are: saikosaponin A 17.56 mg, saikosaponin B1 15.46 mg, saikosaponin B2 11.98 mg, saikosaponin C 12.84 mg, saikosaponin D 11.56 mg, saikosaponin F 13.86 mg, saikosaponin G 12.44 mg, saikosaponin H 13.55 mg, saikosaponin I 12.83 mg, niposaponin K 4.91 mg, saikosaponin S 13.88 mg, prosapogenin D 11.03 mg, and prosapogenin F 11.03 mg, accurately add 80% methanol to dissolve, and prepare saikosaponin A containing 702.4 μg / mL, saikosaponin B1 70.4 mg, saikosaponin B2 11.98 mg, saikosaponin C 12.84 mg, saikosaponin D 11.56 mg, saikosaponin F 13.86 mg, saikosaponin G 12.44 mg, saikosaponin H 13.55 mg, saikosaponin I 12.83 mg, niposaponin K 4.91 mg, saikosaponin S 13.88 mg, prosapogenin D 11.03 mg, and prosapogenin F 11.03 mg, respectively. Precisely pipette 750 μL of each of the 13 reference substance mother solutions into a 10 mL volumetric flask, dilute to volume with 80% methanol to make a stock solution containing saikosaponin A 618.4 μg / mL, saikosaponin B2 479.2 μg / mL, saikosaponin C 513.6 μg / mL, saikosaponin D 462.4 μg / mL, saikosaponin F 554.4 μg / mL, saikosaponin G 497.6 μg / mL, saikosaponin H 542.0 μg / mL, saikosaponin I 513.2 μg / mL, niposaponin K 491.0 μg / mL, saikosaponin S 555.2 μg / mL, prosapogenin D 441.2 μg / mL, and prosapogenin F 441.2 μg / mL. 52.68μg / mL, saikosaponin B1 46.38μg / mL, saikosaponin B2 35.94μg / mL, saikosaponin C 38.52μg / mL, saikosaponin D 34.68μg / mL, saikosaponin F 41.58μg / mL, saikosaponin G 37.32μg / mL, saikosaponin H 40.65μg / mL, saikosaponin I 38.49μg / mL, niposaponin K 36.825μg / mL, saikosaponin S 41.64μg / mL, prosapogenin D 33.09μg / mL, prosapogenin F33.09μg / mL of 13 kinds of saikosaponin mixed reference solution; dilute the 13 kinds of saikosaponin mixed reference solution 5 times, 10 times, 25 times, 50 times, 75 times, 100 times, 250 times, 500 times, 750 times and 1000 times respectively, insert the needle, and calculate the standard curve, which is used for the quantitative calculation of various saponins in the Chaihuang preparation.

[0019] According to the method of the first aspect of the present invention, the method for preparing the Bupleurum medicinal material test solution required for the determination is as follows: take a 0.5g sample of Bupleurum, accurately weigh it, put it in a stoppered conical flask, accurately add 25ml of a methanol solution containing 5% concentrated ammonia test solution, stopper it, weigh it, ultrasonically treat it (power 500W, frequency 40kHz) for 30 minutes, take it out, cool it, weigh it again, make up the lost weight with a methanol solution containing 5% concentrated ammonia test solution, shake it well, filter it with a 0.22μm microporous filter membrane, and obtain it.

[0020] According to the method of the first aspect of the present invention, the method for preparing the decocted test solution of Bupleurum chinense required for determination is as follows: take 10g of various Bupleurum chinense respectively, add water and decoct twice, each time for 4 hours, filter the decoction, combine the filtrate, concentrate, and make an extract; take a sample extract equivalent to 0.5g of Bupleurum chinense, accurately weigh it, put it in a stoppered conical flask, accurately add 25ml of methanol solution containing 5% concentrated ammonia test solution, seal it, weigh it, ultrasonically treat it (power 500W, frequency 35kHz) for 30 minutes, take it out, cool it, weigh it again, make up the lost weight with methanol solution containing 5% concentrated ammonia test solution, shake it well, filter it with a 0.22μm microporous filter membrane, and obtain it.

[0021] According to the method of the first aspect of the present invention, the method for preparing the Chaihuang preparation test solution required for determination is as follows: take a Chaihuang preparation sample equivalent to 0.5g of Chaihu medicinal material, accurately weigh it, put it in a stoppered conical flask, accurately add 25ml of methanol solution containing 5% concentrated ammonia test solution, seal it, weigh it, ultrasonically treat it (power 500W, frequency 40kHz) for 30 minutes, take it out, cool it, weigh it again, make up the lost weight with methanol solution containing 5% concentrated ammonia test solution, shake it well, and filter it with a 0.22μm microporous filter membrane to obtain; or, according to the method of the first aspect of the present invention, the preparation of the Chaihuang preparation test solution required for determination is to use the Chaihuang method including the following operations: The preparation is prepared by a modified preparation method for the test sample solution: take a sample of the Chaihuang preparation equivalent to 0.5g of Bupleurum medicinal material, accurately weigh it, put it in a stoppered conical flask, add 25ml of ether and 0.5ml of 10% sodium hydroxide, seal it, ultrasonically treat it (power 500W, frequency 40kHz) for 10 minutes, filter it, and then wash the residue with 20ml of ether. The ether is evaporated from the residue, and 25ml of methanol solution containing 5% concentrated ammonia test solution is accurately added, seal it, weigh it, and ultrasonically treat it (power 500W, frequency 40kHz) for 30 minutes. Take it out, cool it, weigh it again, make up the lost weight with methanol solution containing 5% concentrated ammonia test solution, shake it well, and filter it with a 0.22μm microporous filter membrane to obtain it.

[0022] According to the method of the first aspect of the present invention, when using liquid chromatography-tandem electrostatic field orbital trap high-resolution mass spectrometry to measure samples, 5 μl of each test solution is accurately aspirated and injected into a high performance liquid chromatography-mass spectrometer for measurement, and the content of various saponins in the test solution is calculated using a standard curve.

[0023] The method of the present invention has achieved satisfactory technical effects, especially being able to simultaneously determine the contents of 13 saponins derived from Bupleurum in a Bupleurum preparation within a short time of 20 minutes. BRIEF DESCRIPTION OF THE DRAWINGS

[0024] Figure 1 to Figure 7 These are the ion patterns in the LC-MS analysis of 13 saikosaponins. In each figure, SSS represents saikosaponin S, CF represents prosapogenin F, SSCD represents prosapogenin D, and other abbreviations have similar meanings. DETAILED DESCRIPTION

[0025] The present invention can be further described by the following examples, however, the scope of the present invention is not limited to the following examples. It will be appreciated by those skilled in the art that various changes and modifications may be made to the present invention without departing from the spirit and scope of the present invention. The present invention provides general and / or specific descriptions of the materials and test methods used in the test. Although many materials and operating methods used to achieve the purpose of the present invention are well known in the art, the present invention is still described in as much detail as possible herein. The following examples further illustrate the present invention, rather than limiting the present invention.

[0026] Experimental Example 1: UPLC-Q Exactive-MS Determination of Characteristic Components of Bupleurum in Chaihuang Preparations

[0027] The following is a simultaneous determination of the characteristic components in Bupleurum chinense medicinal materials, decoction pieces and their water extracts, and Chaihuang preparations using ultra-high performance liquid chromatography tandem electrostatic field orbital trap high-resolution mass spectrometry (UPLC-Q Exactive-MS) technology. The chromatographic conditions and mass spectrometry conditions are detailed below. Based on the UPLC-Q Exactive-MS content determination methodology for the characteristic components of saikosaponins in Chaihuang preparations, a content determination method was established. Chaihuang preparation samples from multiple manufacturers were collected from all over the country for analysis.

[0028] 1. Medicinal materials used in the experiment

[0029] 70 batches of commercially available Bupleurum samples were collected, including: 45 batches of northern Bupleurum (8 of which were adulterated), 11 batches of Tibetan Bupleurum, 4 batches of southern Bupleurum, 7 batches of cone-leaved Bupleurum, 1 batch of silver Bupleurum, and 2 batches of Solidago asiatica. Some of the medicinal materials and their sources as well as batch numbers (or self-numbered) are detailed in Table 1 below.

[0030] Table 1

[0031]

[0032]

[0033] 2. Saponin reference substance

[0034] Detailed information of the reference substances of the 13 saikosaponins detected in the present invention is shown in Table 2 below.

[0035] 3. Preparation of mixed reference solution and standard curve:

[0036] Accurately weigh appropriate amounts of reference substances, including: saikosaponin A 17.56 mg, saikosaponin B1 15.46 mg, saikosaponin B2 11.98 mg, saikosaponin C 12.84 mg, saikosaponin D 11.56 mg, saikosaponin F 13.86 mg, saikosaponin G 12.44 mg, saikosaponin H 13.55 mg, saikosaponin I 12.83 mg, niposaponin K 4.91 mg, saikosaponin S 13.88 mg, prosapogenin D 11.03 mg, and prosapogenin F 11.03 mg, and accurately add 80% methanol to dissolve them to prepare saikosaponin A 702.4 μg / mL, saikosaponin B1 618.4 μg / mL, saikosaponin B2 60. The control substance stock solutions were as follows: 479.2μg / mL, saikosaponin C 513.6μg / mL, saikosaponin D 462.4μg / mL, saikosaponin F 554.4μg / mL, saikosaponin G 497.6μg / mL, saikosaponin H 542.0μg / mL, saikosaponin I 513.2μg / mL, niposaponin K 491.0μg / mL, saikosaponin S 555.2μg / mL, prosapogenin D 441.2μg / mL, and prosapogenin F 441.2μg / mL. Accurately pipette 750 μL of each of the 13 reference substance mother solutions into a 10 mL volumetric flask, dilute to the mark with 80% methanol to prepare a flask containing 52.68 μg / mL of saikosaponin A, 46.38 μg / mL of saikosaponin B1, 35.94 μg / mL of saikosaponin B2, 38.52 μg / mL of saikosaponin C, 34.68 μg / mL of saikosaponin D, 41.58 μg / mL of saikosaponin F, 37.32 μg / mL of saikosaponin G, 40.65 μg / mL of saikosaponin H, 38.49 μg / mL of saikosaponin I, 36.825 μg / mL of niposaponin K, 41.64 μg / mL of saikosaponin S, 33.09 μg / mL of prosapogenin D, and 37.70 μg / mL of prosapogenin F. F33.09μg / mL 13 kinds of saikosaponin mixed reference solution. The 13 kinds of saikosaponin mixed reference solution were diluted 5 times, 10 times, 25 times, 50 times, 75 times, 100 times, 250 times, 500 times, 750 times and 1000 times respectively, and the needle was inserted to calculate the standard curve, which was used for the quantitative calculation of various saponins in the Chaihuang preparation.

[0037] 4. Measurement conditions

[0038] An ultra-high performance liquid chromatography coupled to an electrostatic field orbital trap high-resolution mass spectrometer (UPLC-Q Exactive-MS, which may be referred to as chromatography-mass spectrometer, LC-MS, UPLC-MS, etc. in the present invention) was used.

[0039] Chromatographic conditions: The chromatographic column was phenomenex C18 (2.1×150 mm, 1.7 μm), with 0.1% formic acid aqueous solution as mobile phase A and methanol as mobile phase B, gradient elution was used, and the flow rate was 0.25 mL / min. The elution gradient was as follows: 0-1 min, 2% B; 1.0-2.5 min, 2%-60% B; 2.5-6.5 min, 60%-90% B; 6.5-7.5 min, 90%-100% B; 7.5-9.5 min, 100% B; 9.5-9.6 min, 100%-2% B; 9.6-15.0 min, 12% B. The column temperature was 25°C, and the injection volume was 5 μL.

[0040] Mass spectrometry conditions: positive and negative ion online detection mode, ESI source, ion source temperature 300°C, capillary temperature 350°C; cone voltage 3.0 kV; sheath gas flow 50 psi; auxiliary gas flow 10 psi; S-Lens RF 30%, scanning range m / z 110-800; resolution 75000.

[0041] The molecular weight and chemical formula of each reference substance are shown in Table 2.

[0042] Table 2

[0043] No Chinese name English name Methods for quantitative molecular weight Chemical formula Reference Material Supplier 1 Saikosaponin A Saikosaponin A 825.46419(+HCOOH) C42H68O13 China Food and Drug Inspection Institute 2 Saikosaponin B1 Saikosaponin B1 825.46419(+HCOOH) C42H68O13 Lemeitian Pharmaceuticals | Dester Biotech 3 Saikosaponin B2 Saikosaponin B2 825.46419(+HCOOH) C42H68O13 Lemeitian Pharmaceuticals | Dester Biotech 4 Saikosaponin C Saikosaponin C 971.5221(+HCOOH) C48H78O17 Lemeitian Pharmaceuticals | Dester Biotech 5 Saikosaponin D Saikosaponin D 825.46419(+HCOOH) C42H68O13 China Food and Drug Inspection Institute 6 Saikosaponin G Saikosaponin G 825.46419(+HCOOH) C42H68O13 Lemeitian Pharmaceuticals | Dester Biotech 7 Saikosaponin H Saikosaponin H 971.5221(+HCOOH) C48H78O17 Lemeitian Pharmaceuticals | Dester Biotech 8 Niposide K Nepasaikosaponin K 989.53267(+HCOOH) C48H80O18 NATURE STANDARD 9 Saikosaponin S Saikosaponin S 987.51702(+HCOOH) C48H78O18 Beijing Saibaicao Technology Co., Ltd. 10 Saikosaponin I Saikosaponin I 971.5221(+HCOOH) C48H78O17 Lemeitian Pharmaceuticals | Dester Biotech 11 Prosapogenin D Prosaikogenin D 663.41137(+HCOOH) C36H58O8 Lemeitian Pharmaceuticals | Dester Biotech 12 Saikosaponin F Saikosaponin F 973.53775(+HCOOH) C48H80O17 Lemeitian Pharmaceuticals | Dester Biotech 13 Prosapogenin F Prosaikogenin F 617.40589 C36H58O8 Beijing Saibaicao Technology Co., Ltd.

[0044] 5. Sample preparation and determination

[0045] Preparation of Bupleurum medicinal material test solution: Take 0.5g sample of Bupleurum, accurately weigh it, put it in a stoppered conical flask, accurately add 25ml of methanol solution containing 5% concentrated ammonia test solution, stopper it, weigh it, and treat it ultrasonically (power 500W, frequency 40kHz) for 30 minutes. Take it out, cool it, weigh it again, make up the lost weight with methanol solution containing 5% concentrated ammonia test solution, shake it well, and filter it with a 0.22μm microporous filter membrane to obtain it.

[0046] Preparation of the test solution of Bupleurum water extract (i.e. decoction): Take 10g of each Bupleurum, add water and decoct twice, each time for 4 hours, filter the decoction, combine the filtrate, and concentrate to make an extract. Take a sample extract equivalent to 0.5g of Bupleurum, accurately weigh it, put it in a stoppered conical bottle, accurately add 25ml of methanol solution containing 5% concentrated ammonia test solution, stopper it, weigh it, ultrasonically treat it (power 500W, frequency 35kHz) for 30 minutes, take it out, cool it, weigh it again, make up the lost weight with methanol solution containing 5% concentrated ammonia test solution, shake it well, filter it with a 0.22μm microporous filter membrane, and you are done.

[0047] Preparation of the test solution of Chaihuang preparation: Take a sample of Chaihuang preparation equivalent to 0.5g of Chaihu medicinal material, accurately weigh it, put it in a stoppered conical flask, accurately add 25ml of methanol solution containing 5% concentrated ammonia test solution, stopper it, weigh it, and treat it ultrasonically (power 500W, frequency 40kHz) for 30 minutes. Take it out, cool it, weigh it again, make up the lost weight with methanol solution containing 5% concentrated ammonia test solution, shake it well, and filter it with a 0.22μm microporous filter membrane to obtain it.

[0048] Determination method: Accurately pipette 5 μl of each test solution and inject it into the HPLC-MS / MS instrument respectively for determination. Use the standard curve to calculate the content of various saponins in the test solution.

[0049] 6. Methodological specificity assessment

[0050] Under the above chromatographic-mass spectrometric conditions, the ion patterns of 13 saikosaponins are shown in Figure 1 to Figure 7 As can be seen from the figure, the 13 saikosaponins are well separated. In the figure, SSS represents saikosaponin S, CF represents Prosapogenin F, SSCD represents Prosapogenin D, and other abbreviations have similar meanings. In addition, under the above-mentioned chromatography-mass spectrometry conditions of the present invention, all 13 saponins can be tested within 20 minutes.

[0051] 7. Linear relationship and limit of quantitation

[0052] Select the Chaihuang preparation (Chaihuang granules No. 41) and add 13 kinds of saikosaponin mixed reference solution ①, dilute 1.333333333 times (saikosaponin mixed reference solution ②), 2 times (saikosaponin mixed reference solution ③), 4 times (saikosaponin mixed reference solution ④), 10 times (saikosaponin mixed reference solution ⑤), 13.33333333 times (saikosaponin mixed reference solution ⑥), 20 times (saikosaponin mixed reference solution ⑦), 40 times (saikosaponin mixed reference solution ⑧), 100 (saikosaponin mixed reference solution ⑨), 200 times (saikosaponin mixed reference solution ⑩), prepare the matrix standard curve, take the peak area (Y) of the chromatographic peak of the test compound as the ordinate, and perform linear regression with the injection concentration (X, ng / L). The linear range, regression equation and correlation coefficient are shown in Table 4 below. The data of the lowest concentration point in the linear equation were used to calculate the detection limits of 13 saponins according to a 3-fold signal-to-noise ratio, and the quantification limits of 13 saponins were calculated according to a 10-fold signal-to-noise ratio. The results are shown in Table 4. These results show that the Chaihuang preparation still has an excellent linear relationship after adding the reference substance, and the detection limit and quantification limit can meet the general requirements of drug analysis.

[0053] 8. Methodological recovery and precision test

[0054] Take 9 samples of Chaihuang preparation (Chaihuang granules No. 40) of 0.125g, 0.25g, and 0.5g, and add 50, 100, and 200μL of saikosaponin mixed reference solution at low, medium, and high levels, respectively. Each spiked level is repeated 3 times. The test solution is prepared and measured according to the above method, and the recovery rate and relative standard deviation of each saikosaponin are calculated. See Table 3.

[0055] Table 3

[0056]

[0057]

[0058] The results of the recovery rate and precision of the method in the above table indicate that the recovery rate of individual saponins of this method fluctuates greatly, and the relative standard deviation of the recovery rates of different saponins is also quite large, which is not ideal from the perspective of drug analysis. In order to overcome the above problems, the present invention changes the operation of the "Preparation of Chaihuang Preparation Test Solution" item in the above "5. Preparation and Determination of Samples" of Test Example 1 to the following method (which can be referred to as "Revised Preparation Method of Chaihuang Preparation Test Solution" in the present invention): Take a Chaihuang preparation sample equivalent to 0.5g of Chaihu medicinal material, accurately weigh it, put it in a stoppered conical flask, add 25ml of ether and 0.5ml of 10% sodium hydroxide, seal it, and ultrasonically treat it (power 500W, frequency 40kHz) for 10 minutes, filter it, and then wash the residue with 20ml of ether. The residue evaporates the ether, accurately add 25ml of methanol solution containing 5% concentrated ammonia test solution, seal it, weigh it, and ultrasonically treat it (power 500W, frequency 40kHz) for 30 minutes, take it out, let it cool, and weigh it again. Make up the lost weight with a methanol solution containing 5% concentrated ammonia test solution, shake it well, and filter it with a 0.22μm microporous filter membrane to obtain it. The inventors unexpectedly found that when the modified preparation method of the Chaihuang preparation test solution is used in the preparation of the test solution, excellent method recovery and precision of all 13 saponins can be obtained. In a supplementary test, namely supplementary test A, the modified preparation method of the Chaihuang preparation test solution is used to conduct methodological recovery and precision tests: 0.125g, 0.25g, and 0.5g of the Chaihuang preparation (Chaihuang granules No. 40) samples are taken, and 9 portions in total are added with saikosaponin mixed reference solution ① 50, 100, and 200 μL at three levels of low, medium, and high, respectively, and 3 portions are paralleled for each spiked level. The test solution is prepared and measured according to the modified preparation method of the Chaihuang preparation test solution, and the recovery and relative standard deviation of each saikosaponin are calculated; as a result, the precision (RSD) of the 13 saponins is within the range of 0.84% ​​to 2.37%, for example, the RSD of saikosaponin G is 2.37%, and the RSD of Prosapogenin G is 2.37%. The RSD of D was 1.51%, and the recoveries of the 13 saponins were all within the range of 89% to 95%. For example, the recoveries of saikosaponin A were 92.4%, 90.1%, and 91.7% respectively. This result shows that the modified preparation method using the Chaihuang preparation test solution can significantly improve the methodological recovery and precision. In a supplementary test, namely, supplementary test B, referring to supplementary test A, but changing the ether-sodium hydroxide in the modified preparation method of the Chaihuang preparation test solution to ether, that is, without adding sodium hydroxide, the same methodological recovery and precision test was carried out. As a result, the precision of the 13 saponins fluctuated within the range of 1.36 to 11.62%. For example, the precision of Prosapogenin F was 8.68%, indicating that sodium hydroxide is indispensable in the modified preparation method.In a supplementary test, namely, supplementary test C, referring to supplementary test A, but when the ether in the ether-sodium hydroxide in the modified preparation method of the above-mentioned Chaihuang preparation test solution was replaced with an equal amount of acetone, the methodological recovery rate and precision test were also carried out. As a result, the precision of the 13 saponins fluctuated within the range of 0.92-13.24%, for example, the precision of saikosaponin I was 5.61%, indicating that the ether in the above-mentioned modified preparation method cannot be easily replaced. Therefore, in one embodiment of the present invention, when preparing the Chaihuang preparation test solution, the modified preparation method of the Chaihuang preparation test solution is adopted. In a supplementary test, namely, supplementary test D, referring to supplementary test A but the tested Chaihuang preparation was Chaihuang Capsule No. 47, the recovery rate and relative standard deviation of each saikosaponin were determined / calculated; as a result, the precision (RSD) of the 13 saponins were all in the range of 0.97% to 2.21%, for example, the RSD of saikosaponin G was 1.85%, and the recoveries of the 13 saponins were all in the range of 91% to 96%, for example, the recoveries of saikosaponin A measured three times were 93.7%, 91.5%, and 94.4%, respectively. In a supplementary test, namely supplementary test E, referring to supplementary test A, but the tested Chaihuang preparation was No. 50 Chaihuang tablets, the recovery rate and relative standard deviation of each saikosaponin were determined / calculated; as a result, the precision (RSD) of the 13 saponins were all within the range of 1.14% to 2.63%, for example, the RSD of saikosaponin G was 2.14%, and the recovery rates of the 13 saponins were all within the range of 88% to 94%, for example, the recovery rates of saikosaponin A measured three times were 92.3%, 89.2%, and 90.7%, respectively. It can be seen that the method of the present invention is suitable for the determination of the content of 13 saponins in various Chaihuang preparations. In other supplementary experiments, it has been found that the "Preparation of Bupleurum Root Drug Sample Solution" and "Preparation of Bupleurum Root Decoction Test Solution" in the above "5. Sample Preparation and Determination" can achieve a recovery rate of more than 97% when testing Bupleurum Root Drug and Bupleurum Root Decoction Test Samples, and the precision RSD is below 2%, indicating that the methodological recovery rate and precision are excellent for Bupleurum Root Drug and Bupleurum Root Decoction Test Samples.

[0059] 9. Testing of Chaihuang preparation samples

[0060] 52 samples of the Chaihuang preparation series obtained by the present invention were selected, including 46 batches of granules, 3 batches of capsules, and 3 batches of tablets. The contents of characteristic components in some typical Chaihuang preparations were determined according to the above-mentioned operation method (including the operation of the modified preparation method of the test solution of the Chaihuang preparation). The results of the determination of the contents of characteristic components in the Chaihuang preparations are shown in Table 4 (unit: μg / g).

[0061] Table 4

[0062]

[0063] It can be seen from the results in the table that the LC-MS method of the present invention can simultaneously determine the contents of 13 saponins in Chaihuang granules, Chaihuang capsules and Chaihuang tablets.

[0064] 10. Test results of Bupleurum chinense

[0065] The present invention uses the method described above to determine the content of 13 saponins in Bupleurum. The results show that among the 13 saponins, saikosaponin a and d are the highest. Except for individual samples, the contents of northern Bupleurum and southern Bupleurum are higher than 100 μg / g, while the contents of a and d in cone-leaf Bupleurum are significantly lower than those in northern Bupleurum. The contents of saponins in other non-Bupleurum species such as Solidago scabra and Bupleurum argentea are extremely small. By observing the properties of the medicinal materials, a small amount of Bupleurum or Bupleurum plants are mixed. Nepasaikosaponin K content is found to be higher in Tibetan Bupleurum, which is about 25 to 650 times higher than other genuine Bupleurum (except for some Tibetan Bupleurum varieties), so this index can be used as an indicator component for distinguishing Tibetan Bupleurum as a reference. Prosapogenin D content is found to be about 4 to 200 times higher in cone-leaf Bupleurum than in other Bupleurum, so this index can be used as an indicator component for distinguishing cone-leaf Bupleurum as a reference.

[0066] Comparing the changes before and after decocting Bupleurum, the results showed that after decocting, saikosaponin I, G, S, H, B1 and B2 increased significantly, saikosaponin A and D decreased significantly, saikosaponin F, nepasaikosaponin F and C also decreased. Nepasaikosaponin K and nepasaikosaponin D also tended to decrease, but the amplitude was not large. Therefore, as a characteristic indicator, it is relatively stable.

[0067] In the present invention, for the convenience of expression, the term "before decoction" can be understood as "drug pieces", and the term "after decoction" can be understood as "extract".

[0068] The test results of some Bupleurum medicinal materials are shown in Tables 5a and 5b below.

[0069] Table 5a

[0070]

[0071] Continued from Table 5a (B1~S)

[0072]

[0073]

[0074] Continued from Table 5a (G~F)

[0075]

[0076]

[0077] Table 5b

[0078]

[0079] Continued from Table 5b (B1~S)

[0080]

[0081]

[0082] Continued from Table 5b (G~F)

[0083]

[0084]

[0085] The above-described embodiments are only preferred embodiments for fully illustrating the present application, and the protection scope of the present application is not limited thereto. Equivalent substitutions or changes made by technicians in the technical field based on the present application are all within the protection scope of the present application. The protection scope of the present application shall be subject to the claims.

Claims

1. A method for determining the content of saikosaponins in a Chaihuang preparation, the method using ultra-high performance liquid chromatography-tandem electrostatic field orbital trap high-resolution mass spectrometry to simultaneously determine the following saikosaponins in the Chaihuang preparation and calculate their contents: saikosaponin A, saikosaponin B1, saikosaponin B2, saikosaponin C, saikosaponin D, saikosaponin F, saikosaponin G, saikosaponin H, saikosaponin I, saikosaponin K, saikosaponin S, prosapogenin D, prosapogenin F; the Chaihuang preparation is selected from Chaihuang granules, Chaihuang capsules, Chaihuang tablets, Chaihuang oral liquid, and Chaihuang soft capsules; wherein, The chromatographic conditions of the ultra-high performance liquid chromatography-tandem electrostatic field orbital trap high-resolution mass spectrometry are as follows: the chromatographic column is phenomenex C18, 0.1% formic acid aqueous solution is used as mobile phase A, methanol is used as mobile phase B, gradient elution is used, and the flow rate is 0.25 mL / min; the elution gradient is as follows: 0-1 min, 2% B; 1.0-2.5 min, 2%-60% B; 2.5-6.5 min, 60%-90% B; 6.5-7.5 min, 90%-100% B; 7.5-9.5 min, 100% B; 9.5-9.6 min, 100%-2% B; 9.6-15.0 min, 12% B; column temperature is 25°C, and the injection volume is 5 μL; The mass spectrometry conditions of the ultra-high performance liquid chromatography-tandem electrostatic field orbital trap high-resolution mass spectrometry are as follows: positive and negative ion online detection mode, ESI source, ion source temperature 300°C, capillary temperature 350°C; cone voltage 3.0 kV; sheath gas flow 50 psi; Auxiliary gas flow 10psi; S-Lens RF 30%, scanning range m / z110-800; resolution 75000; Preparation of mixed reference solution and standard curve: accurately weigh appropriate amount of reference substances, the weighed amounts are: saikosaponin A 17.56 mg, saikosaponin B1 15.46 mg, saikosaponin B2 11.98 mg, saikosaponin C 12.84 mg, saikosaponin D 11.56 mg, saikosaponin F 13.86 mg, saikosaponin G 12.44 mg, saikosaponin H 13.55 mg, saikosaponin I 12.83 mg, niposaponin K 4.91 mg, saikosaponin S 13.88 mg, prosapogenin D 11.03 mg, prosapogenin F 11.03 mg, accurately add 80% methanol to dissolve, and prepare saikosaponin A 702.4 μg / mL, saikosaponin B1 702.4 μg / mL, saikosaponin B2 702.4 μg / mL, saikosaponin C 702.4 mg, saikosaponin D 702.4 μg / mL, saikosaponin F 702.4 μg / mL, saikosaponin G 702.4 mg, saikosaponin H 702.4 mg, saikosaponin I 702.4 μg / mL, saikosaponin K 702.4 μg / mL, saikosaponin S 702.4 μg / mL, saikosaponin B2 702.4 μg / mL, saikosaponin C 702.4 mg, saikosaponin D 702.4 μg / mL, saikosaponin F 702.4 μg / mL, saikosaponin G 702.4 mg, saikosaponin H 702.4 mg, saikosaponin I 702. Precisely pipette 750 μL of each of the 13 reference substance mother solutions into a 10 mL volumetric flask, dilute to volume with 80% methanol to make a stock solution containing saikosaponin A 618.4 μg / mL, saikosaponin B2 479.2 μg / mL, saikosaponin C 513.6 μg / mL, saikosaponin D 462.4 μg / mL, saikosaponin F 554.4 μg / mL, saikosaponin G 497.6 μg / mL, saikosaponin H 542.0 μg / mL, saikosaponin I 513.2 μg / mL, niposaponin K 491.0 μg / mL, saikosaponin S 555.2 μg / mL, prosapogenin D 441.2 μg / mL, and prosapogenin F 441.2 μg / mL. 52.68μg / mL, saikosaponin B146.38μg / mL, saikosaponin B2 35.94μg / mL, saikosaponin C 38.52μg / mL, saikosaponin D 34.68μg / mL, saikosaponin F 41.58μg / mL, saikosaponin G 37.32μg / mL, saikosaponin H 40.65μg / mL, saikosaponin I 38.49μg / mL, niposaponin K 36.825μg / mL, saikosaponin S 41.64μg / mL, prosapogenin D 33.09μg / mL, prosapogenin F 33.09 μg / mL of 13 kinds of saikosaponin mixed reference solution; dilute the 13 kinds of saikosaponin mixed reference solution 5 times, 10 times, 25 times, 50 times, 75 times, 100 times, 250 times, 500 times, 750 times and 1000 times respectively, insert the needle, calculate the standard curve, and the standard curve is used for the quantitative calculation of various saponins in the Chaihuang preparation; Preparation of the test solution of Chaihuang preparation: Take a sample of Chaihuang preparation equivalent to 0.5g of Chaihu medicinal material, accurately weigh it, put it in a stoppered conical flask, add 25ml of ether and 0.5ml of 10% sodium hydroxide, seal it tightly, treat it ultrasonically for 10 minutes, filter it, and then wash the residue with 20ml of ether. After the residue is evaporated, ether is evaporated, accurately add 25ml of methanol solution containing 5% concentrated ammonia test solution, seal it tightly, weigh it, treat it ultrasonically for 30 minutes, take it out, let it cool, weigh it again, make up the lost weight with methanol solution containing 5% concentrated ammonia test solution, shake it well, and filter it with a 0.22μm microporous filter membrane to obtain it; Determination: Accurately pipette 5 μl of the test solution, inject it into the HPLC-MS / MS instrument, and determine. Use the standard curve to calculate the content of various saponins in the test solution.

2. The method according to claim 1, wherein the chromatographic column used in the chromatographic conditions of the ultra-high performance liquid chromatography-tandem electrostatic field orbital trap high-resolution mass spectrometry is phenomenex C18, and the column specifications are 2.1×150 mm, 1.7 μm.

3. according to the method for claim 1, the operating conditions of wherein said ultrasonic treatment are: power 500W, frequency 40kHz.

4. The method according to any one of claims 1 to 3, wherein the Chaihuang preparation is replaced by Bupleurum chinense medicinal material.

5. The method according to any one of claims 1 to 3, wherein the Chaihuang preparation is replaced by an extract of Bupleurum water extraction.